Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.427 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.429 (Epsilon)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.166EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
AY.99.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.467EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used